SAT-547 Mendelian randomization strengthens the crosstalk of immune traits with primary biliary cirrhosis and primary sclerosing cholangitis.

MLA

Xu, Jing, et al. “SAT-547 Mendelian Randomization Strengthens the Crosstalk of Immune Traits with Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.” Journal of Hepatology, vol. 80, June 2024, p. S357. EBSCOhost, https://doi.org/10.1016/S0168-8278(24)01189-9.

APA

Xu, J., Hao, J., Ling, N., & Peng, M.-L. (2024). SAT-547 Mendelian randomization strengthens the crosstalk of immune traits with primary biliary cirrhosis and primary sclerosing cholangitis. Journal of Hepatology, 80, S357. https://doi.org/10.1016/S0168-8278(24)01189-9

Chicago

Xu, Jing, Jie Hao, Ning Ling, and Ming-Li Peng. 2024. “SAT-547 Mendelian Randomization Strengthens the Crosstalk of Immune Traits with Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis.” Journal of Hepatology 80 (June): S357. doi:10.1016/S0168-8278(24)01189-9.